Parenteral iron—Does it increase infection risk?
Vox Sanguinis · 2026-07 · 121 (7) · 914-922
DOI: 10.1111/vox.70241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vox Sanguinis, online erschienen am 25.03.2026. Verfasst von Joyisa Deb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine & Blood Centre, All India Institute of Medical Sciences, Guwahati, Assam, India. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Iron, Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives Iron deficiency (ID) and iron deficiency anaemia (IDA) are prevalent conditions impacting various patient populations, both surgical and non‐surgical conditions. The advent of patient blood management (PBM) has promoted intravenous (IV) iron therapy as an alternative to oral iron and blood transfusions. However, concerns remain regarding IV iron's potential association with infection risk. This narrative review critically examines the relationship between parenteral iron therapy and infection risk across various clinical settings. It evaluates various IV iron formulations, their benefits, safety profiles and potential adverse effects, particularly infection‐related complications. Materials and Methods A structured literature search was conducted across PubMed, EMBASE, Medline and CINAHL (2014–2024) using pre‐defined keywords. Observational studies and clinical trials relevant to IV iron formulations and infection risk were analysed.
Results
IV iron therapy effectively improves haemoglobin levels and reduces transfusion dependence. Studies in cardiovascular, renal, antenatal and surgical populations suggest that it is difficult to conclude that IV iron therapy significantly increases the risk of infection. Older formulations, high‐dose IV iron therapy and various underlying conditions may elevate infection susceptibility due to increased levels of non–transferrin‐bound iron. Emerging formulations, such as ferric carboxymaltose and ferric derisomaltose, appear to have a more favourable safety profile.
Conclusion
While IV iron remains a cornerstone in ID management, patient‐specific risk factors must be considered. Further research is needed to clarify infection risk variations among different IV iron formulations and patient populations. Optimizing IV iron therapy through individualized approaches may enhance its clinical benefits while minimizing potential adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusion Medicine & Blood Centre, All India Institute of Medical Sciences, Guwahati, Assam, India.
- Department of Transfusion Medicine, All India Institute of Medical Sciences, Bibinagar, Telengana, India.
- Department of Transfusion Medicine, Blood Centre Main Hospital, All India Institute of Medical Sciences, New Delhi, India.
- Department of Transfusion Medicine, Tata Medical Center, Kolkata, India.
- Department of Frailty and Ageing, Hull University Teaching Hospitals NHS Trust, Hull, UK.
- Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, UK.
ORCID-Profile: Suvro Sankha Datta, Yoghini Nagandran, Manideepa Maji, Saikat Mandal
Zitieren
APA
Deb, J., Mohan, A. K., Sil, S., Datta, S. S., Nagandran, Y., Maji, M., Majumder, M. K. H., & Mandal, S. (2026). Parenteral iron—Does it increase infection risk?. Vox Sanguinis, 121(7), 914-922. https://doi.org/10.1111/vox.70241
Vancouver
Deb J, Mohan AK, Sil S, Datta SS, Nagandran Y, Maji M, et al. Parenteral iron—Does it increase infection risk?. Vox Sanguinis. 2026;121(7):914-922. doi:10.1111/vox.70241
BibTeX
@article{Deb2026,
author = {Deb, Joyisa and Mohan, Aswin K and Sil, Suhasini and Datta, Suvro Sankha and Nagandran, Yoghini and Maji, Manideepa and Majumder, Mohammad Kamrul Hassan and Mandal, Saikat},
title = {Parenteral iron—Does it increase infection risk?},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {7},
pages = {914--922},
doi = {10.1111/vox.70241}
}
EUVIMED